A recent Medgadget article discussed a new type of vaccine that doesn’t require cold chain for transport. The vaccine, which was developed by researchers at the University of Queensland and Vaxxas, comes via a high-density microarray patch for a minimally invasive delivery without the use of needles. However, the most impressive part is the formulation’s stability; it can be stored for a month at room temperature, and a week at 104 degrees Fahrenheit. A video with more information can be seen here.
This COVID-19 Vaccine Doesn’t Require Cold Chain
The microarray patch vaccine can be stored for a month at room temperature and remain effective.
Nov 11, 2021
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now